Earnings History Data for Qualigen Therapeutics, Inc. (QLGN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Qualigen Therapeutics, Inc.
Qualigen Therapeutics Inc. is a biotechnology company. It is focused on developing products for the treatment and testing of cancer and infectious diseases. The company's product pipeline consist AS1411 and Gold Nanoparticle ALAN, RAS-F3 and STARS(TM) blood cleansing system, which are in clinical stage. Qualigen Therapeutics Inc., formerly known as Ritter Pharmaceuticals Inc., is based in CA, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16-05-2023 | PM | After the close (May 2) |
QLGN | Qualigen Therapeutics | 5.00 | -0.78 | -0.85 | 0.00 | Qualigen Therapeutics GAAP EPS of -$0.78, revenue of $1.61M [5/16/2023 9:02 AM] |
1.00 | -0.02 (-1.96%) |
1.01 | -0.01 (-0.98%) |
0.83 - 6.50 | 30,075 | 40,000 | 786 | |
| 31-03-2022 | ?? | 9:00 AM ET (Apr 1) |
QLGN | Qualigen Therapeutics, Inc. | 23.29 | -0.15 | 0.00 | 0.00 | Qualigen Therapeutics GAAP EPS of -$0.61, revenue of $5.65M [4/1/2022 9:00 AM] |
0.6353 | -0.02 (-2.44%) |
0.65 | 0.0 (0.00%) |
0.47 - 3.12 | 78,529 | 210,000 | 1,244 | |
| 13-11-2020 | PM | QLGN | Ritter Pharmaceuticals, Inc. | 75.00 | -0.19 | -0.10 | 0.00 | Qualigen Therapeutics EPS misses by $0.61, misses on revenue [11/13/2020 9:09 AM] |
3.44 | -0.06 (-1.58%) |
0.0 | 0.0 (0.00%) |
3.18 - 21.50 | 760,773 | 654,353 | 0 | ||
|
|
||||||||||||||||||